For the year ending 2025-12-31, BLGO made $7,765K in revenue. -$11,780K in net income. Net profit margin of -151.71%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue from contract with customer, including assessed tax | 7,765 | 17,779 | ||
| Product | 3,013 | - | ||
| Service | 1,346 | - | ||
| Cost of goods and services sold | 4,359 | 9,926 | ||
| Gross profit | 3,406 | 7,853 | ||
| Selling, general and administrative expenses | 11,768 | 9,302 | ||
| Research and development | 2,593 | 2,882 | ||
| Impairment expense | 14 | - | ||
| Credit loss expense | 3,886 | - | ||
| Total operating expenses | 18,261 | 12,184 | ||
| Operating loss | -14,855 | -4,331 | ||
| Interest expense | - | -33 | ||
| Grant income | - | 26 | ||
| Ppp forgiveness | 0 | 97 | ||
| Finance fee | 0 | 106 | ||
| Grant income | 6 | - | ||
| Interest income | 200 | - | ||
| Interest expense | 540 | - | ||
| Total other expense | -334 | -16 | ||
| Net loss | -15,189 | -4,347 | ||
| Net loss attributable to noncontrolling interest | -3,409 | -1,945 | ||
| Net loss attributable to common stockholders | -11,780 | -2,402 | ||
| Basic EPS | -0.04 | -0.01 | ||
| Basic Average Shares | 306,954,778 | 298,122,239 | ||
BIOLARGO, INC. (BLGO)
BIOLARGO, INC. (BLGO)